CLINICAL STUDIES
Infectious complications are the leading cause of death in cancer patients. Fungal infection occurs in 20–70 % of patients undergoing chemotherapy with 40 % mortality rate. The efficacy of antifungal agents has been assessed in children undergoing chemotherapy

LABORATORY AND EXPERIMENTAL STUDIES
BRCA1 and BRCA2 may contribute in pancreatic cancer (PC) risk, however the selection criteria for BRCA1 testing are poorly defined. The analysis of Russian founder mutation BRCA1 5382insC in 150 PC patients identified 2 carriers. BRCA2 full-length sequencing of 8 DNA samples revealed 1 mutated allele (BRCA2 5197_5198delTC). All 3 carriers of BRCA1/2 mutations reported personal or familial history of BRCA-related cancers. Thus, BRCA1/2 testing is particularly

The chymotrypsin-like and caspase-like proteasome activities were studied in tumor tissues of 74 patients with breast cancer (BC) NМin association with tumor size and lymph node involvement. Chymotrypsin-like and caspase-like proteasome activities were Т1-40-30 higher in breast cancer tissue than in adjacent tissues. We showed that advanced BC is accompanied by increase in chymotrypsin-like and caspase-like proteasome activities. In tumors with lymph node dissemination, proteasome activity was significantly decreased, which may have prospective prognostic value. Taken together, our data indicate an important role of intracellular proteolysis in BC progression.

ONCOLOGY PRACTICE
REVIEWS
CASE REPORTS
HISTORY OF MEDICINE
OBITUARY
CHRONICLE. INFORMATION
ISSN 2312-3168 (Online)